Governance
Wealth Creation Oversight Group
The Wealth Creation Oversight Group supports the Oxford AHSN Wealth Creation programme in developing regional strategy. It is also plays a role in supporting regional communications and in helping develop key priorities.
Members of the Wealth Creation Oversight Group are:
Simon Greenstreet – Head of Communications & Public Affairs, Bayer
Julie Hart – Director of Strategic and Industry Partnerships, Oxford Academic Health Science Network
Paul Durrands – Chief Operating Officer, Oxford Academic Health Science Network
Barbara Ghinelii – Harwell Campus Business Development Director
Bruce Potter – Chairman, Blake Morgan
Nigel Tipple – Chief Executive, Oxfordshire LEP
Glenn Wells – Chief Operating Officer, Oxford AHSC
Gary Ford – Chief Executive, Oxford Academic Health Science Network
Rochelle Nelson – EA to Julie Hart, Oxford Academic Health Science Network
Chas Bountra – Pro-Vice Chancellor Innovation, University of Oxford and Chief Scientist, Structural Genomics Consortium
Sarah Haywood – Chief Executive, MedCity
John Collins – Chief Operating Officer and Director Technology Implementation, CIMIT
Comments are closed.